PSMA PET/CT用于前列腺癌原发分期——最新综述
本综述汇总当前文献,更新PSMA PET/CT用于前列腺癌原发分期的现状。PSMA PET/CT较传统影像对转移灶检测的灵敏度和特异度更高,联合多参数MRI可提高前列腺外侵犯和精囊侵犯评估的灵敏度,并可使约四分之一患者的临床管理发生改变。但实施PSMA PET/CT原发分期对患者结局的影响尚不明确,需前瞻性研究。
要点
- PSMA PET/CT较传统影像对转移灶检测的灵敏度和特异度更高,可同时评估全身疾病负荷。
- PSMA PET联合多参数MRI较单用多参数MRI提高前列腺外侵犯和精囊侵犯评估的灵敏度。
- PSMA PET/CT较传统影像使约四分之一患者的临床管理发生改变,但对患者结局的影响尚不明确。
核心结论
- PSMA PET/CT用于前列腺癌原发分期日益普及,其诊断准确性优于传统影像并可改变临床管理,但对患者结局的影响尚不明确,需前瞻性研究。
研究设计与样本
- 本文为叙述性综述,旨在汇总当前文献并更新PSMA PET/CT用于前列腺癌原发分期的现状。
主要发现
- PSMA PET/CT较传统影像对转移灶检测具有更高的灵敏度和特异度,可同时评估全身疾病负荷。
- PSMA PET联合多参数MRI较单用多参数MRI提高前列腺外侵犯和精囊侵犯评估的灵敏度。
- PSMA PET/CT较传统影像使约四分之一患者的临床管理发生改变。
- 18F-PSMA-1007的非特异性骨摄取率较高,但尿排泄较低,可能在局部复发检测中具有优势。
关键数值与推荐
- PSMA PET联合多参数MRI可能作为精选的多参数MRI阴性和/或原发活检阴性患者影像引导活检的二线方式。
临床怎么用
- 报告医师需接受适当培训并了解所用特定PSMA示踪剂的陷阱,这对高质量阅片至关重要。
局限性
- 目前实施PSMA PET/CT原发分期对患者结局的影响尚不明确。
- 需开展前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate-specific membrane antigen PET/CT for primary staging of prostate cancer is becoming increasingly popular due to simultaneous assessment of whole-body disease burden, with superior sensitivity and specificity for detecting metastases compared to conventional imaging. PSMA PET in combination with multiparametric MRI (mpMRI) improves the sensitivity of assessment of extra-prostatic extension and seminal vesicle invasion compared to mpMRI alone, and may serve as a second line modality for image-guided biopsy in selected patients with negative mpMRI and/or negative primary biopsies. The superior diagnostic accuracy of PSMA PET/CT affects clinical decision-making with a change of clinical management in one-fourth of patients compared to conventional imaging. However, at present, the effect of implementing PSMA PET/CT for primary staging on patient outcomes is not clear, and prospective studies are warranted. There are several PSMA tracers with similar performance and minor individual pharmacokinetic differences such as higher rate of unspecific bone uptake with 18F-PSMA-1007, but on the other hand, lower urinary excretion, which could give an advantage in the detection of local recurrence. Proper training of the reporting physicians and knowledge of the pitfalls of the specific PSMA tracer used is of utmost importance for high-quality reading. We aim to provide an overview of the current literature and an update on the status of PSMA PET/CT for primary staging of prostate cancer.
引用
- Jochumsen MR, Bouchelouche K. PSMA PET/CT for Primary Staging of Prostate Cancer - An Updated Overview. Semin Nucl Med. 2023. PMID: 37487824. doi:10.1053/j.semnuclmed.2023.07.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。